Strona 4 - Najlepsi lekarze wykonujący mammografię – TOP 152 lekarzy

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Edukacja i specjalizacja

• 2006 : Wydział Lekarski Uniwersytetu Kocaeli
• 2014 : Wydział Lekarski Uniwersytetu Akdeniz, Medycyna Wewnętrzna
• 2018 : Wydział Lekarski Uniwersytetu Akdeniz, Onkologia Medyczna

Doświadczenie

• 2006 - 2008 : Szpital Rejonowy Konya Derebucak
• 2009 - 2015 : Szpital Uniwersytecki w Akdeniz
• 2015 : Szpital Państwowy w Antalyi Kaş
• 2015 - 2016 : Wydział Lekarski Uniwersytetu İnönü
• 2016 - 2021 : Szpital Uniwersytecki w Akdeniz
• 2021 - 2023 : Szpital szkoleniowy i badawczy w Antalyi

Dr. Tarek M. Hashem is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University (since 2020). He is also a Consultant in Breast and Oncoplastic Surgery at Shefa Al Orman Comprehensive Cancer Center in Luxor (2018–present).

Focus: breast cancer management and oncoplastic surgery. Procedures include breast-conserving surgery, mastectomy, and lumpectomy. Axillary staging includes sentinel lymph node biopsy and axillary dissection. He performs reduction mammoplasty and mastopexy. Reconstruction options include implants, expanders, and flaps (LD, TDAP, LICAP, AICAP, TRAM, SEAP), as well as nipple reconstruction and lipofilling. He also performs supermicrosurgery for lymphedema.

Credentials: MBBCh (Kasr El-Aini, Cairo University). MRCS (England, 2008). Master’s in General Surgery (Kasr El-Aini, Cairo University, 2009). International Breast Surgery Fellowship per EUSOMA (Marienhospital Düsseldorf, 2011). Fellowship in Breast Surgery (Heidelberg University Hospital, 2013). Doctoral degree in Surgical Oncology (2015).

Edukacja i wiedza specjalistyczna

• 2010-2016 – WYDZIAŁ MEDYCZNY UNIWERSYTETU EGE
• 2017-2022 – EGE UNIWERSYTET WYDZIAŁ MEDYCZNY ZAKŁAD RADIOLOGII

Choroby

• Radiologia jamy brzusznej
• Radiologia piersi

Metody leczenia

• Biopsje piersi i tarczycy
• Zabiegi interwencyjne i biopsje nienaczyniowe
• Zabiegi drenażu przezskórnego

Doświadczenie

• 2016-2017 – Szpital Państwowy w Uşaku (lekarz pierwszego kontaktu)
• 2017-2022 – Uniwersytet Ege (Szkolenie specjalistyczne)
• 2022-2024 – Szpital Kształcenia i Badań Ağrı (lekarz specjalista)

Członkostwo profesjonalne

• Tureckie Stowarzyszenie Radiologiczne (TRD)
• Tureckie Towarzystwo Radiologii Zabiegowej (TGRD)

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Ozge Utku Aydemir is a specialist in plastic, reconstructive, and aesthetic surgery. Dr. Aydemir completed residency training at Ankara Bilkent City Hospital (2019–2023). Dr. Aydemir then served as a specialist doctor at Ankara Ataturk Sanatorium Training and Research Hospital (2023–2025). Dr. Aydemir earned an MD from Gazi University (English Program).

EBOPRAS (European Board of Plastic, Reconstructive and Aesthetic Surgery) Part 1 certified on 25 Jan 2025. Interests include facial and breast aesthetics, body contouring, microsurgery and hand surgery, reconstructive surgery, injectables (fillers, Botox), and lasers.

Publications include a 2023 article in The Journal of Hand Surgery on outcomes of wide-awake flexor tendon repairs in 58 fingers and 9 thumbs. Dr. Aydemir also completed a thesis on amniotic membrane use in flexor tendon repair. Presentations include oral and poster sessions at TPRECD and an international congress. Member of TPRECD, Aesthetic Plastic Surgery Society, and Aesthetic Surgery Society.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Dr. Siripong Lakkhanawong, MD, is a specialist in Family Medicine, General Surgery, and Plastic Surgery. He has more than 25 years of medical experience.

He provides patient-focused care with a strong emphasis on safety and professional standards. His work centers on general and plastic surgery. His goal is to achieve consistent, long-lasting surgical outcomes.

uzmanlik

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Specjalizacje

Radiologia jamy brzusznej

Radiologia Dopplera

Radiologia położnicza

Radiologia piersi

Radiologia układu mięśniowo-szkieletowego

Radiologia dziecięca

Neuroradiologia

Zabiegi interwencyjne nienaczyniowe

Doświadczenie

Klinika Radiologii Szpitala Liman

Centrum Medyczne Akademii

Centrum Medyczne Anaclinic

Szpital państwowy w Kayseri

Klinika Radiologii Uniwersytetu Kayseri Erciyes

Prywatne Centrum Medyczne Samsun Midiliv

Szpital Samsun Büyük Anadolu (2023)

Education

Doctor of Medicine (M.D.) degree from Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 2022

Certifications

Certification of Anti-aging and Regenerative Medicine from The American Board of Antiaging and Regenerative Medicine (ABAARM)

Certification of Nutritional Wellness from The American

Naturopathic Certification Board (ANCB)

Clinical Focus

General disease diagnosis and treatment, as well as wellness care

Languages spoken: Thai and English

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr Joseba Rebollo Liceaga jest doświadczonym onkologiem z wszechstronną wiedzą w dziedzinie onkologii.

Edukacja i szkolenia:

Ukończył studia medyczne i chirurgiczne na Uniwersytecie Nawarry (1985).

Ukończył rezydenturę z onkologii w 1987 roku.

Specjalista onkologii medycznej w Clínica Universidad de Navarra (1991).​

Doświadczenie zawodowe:

Kierownik Oddziału Onkologii w Clínica San Miguel de Navarra (1991–2004).​

Lekarz adiunkt w klinice uniwersyteckiej Wydziału Lekarskiego Uniwersytetu Nawarry (1995–2002).​

Lekarz adiunkt na oddziale onkologicznym w szpitalu Quirónsalud w Torrevieja (2004–2014).

Kierownik Oddziału Onkologii w Szpitalu Generalnym de Villalba (2014–2019).​

Obecnie pracuje jako specjalista onkologii klinicznej w Quirónsalud Alicante.

Certyfikaty i szkolenia:

Ukończyłem wiele akredytowanych kursów z zakresu onkologii wielodyscyplinarnej w latach 2003-2006.

Badania i publikacje:

Autor badań dotyczących elektrochemioterapii i wielodyscyplinarnych metod leczenia onkologicznego.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.